Oncological outcomes from trimodality therapy receiving definitive doses of neoadjuvant chemoradiation (≥60 Gy) and factors influencing consideration for surgery in stage III non-small cell lung cancer

PURPOSE: Guidelines for locally advanced non-small cell lung cancer (LA-NSCLC) recommend definitive chemoradiation therapy (CRT) for cN2-N3 disease, reserving surgery for patients with minimal nodal involvement at presentation. The current literature suggests that surgery after CRT for stage III NSC...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Adv Radiat Oncol
Autori principali: Vyfhuis, Melissa A.L., Bhooshan, Neha, Burrows, Whitney M., Turner, Michelle, Suntharalingam, Mohan, Donahue, James, Nichols, Elizabeth M., Feliciano, Josephine, Bentzen, Søren M., Badiyan, Shahed, Carr, Shamus R., Friedberg, Joseph, Simone, Charles B., Edelman, Martin J., Feigenberg, Steven J., Mohindra, Pranshu
Natura: Artigo
Lingua:Inglês
Pubblicazione: Elsevier 2017
Soggetti:
ROI Value of RT Publication Award Winner
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5605306/
https://ncbi.nlm.nih.gov/pubmed/29114590
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.adro.2017.07.009
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi